Literature DB >> 19341180

Reactive arthritis.

Brygida Kwiatkowska1, Anna Filipowicz-Sosnowska.   

Abstract

Reactive arthritis (ReA) is a non-purulent joint inflammation that usually follows bacterial gastrointenstinal or urogenital infections. The classic presentation of ReA is characterized by an asymmetric arthritis usually in the lower limbs associated with urethritis, conjunctivitis and occurrence of other articular or extra-articular manifestations. ReA is classified as a type of seronegative spondyloarthopathy. Approximately 65-85% of patients with ReA are HLA-B27 positive. Regardless of the preceding infection, the clinical picture is similar, but management can differ according to the triggering infection. Treatment of Chlamydia-induced ReA should be started with antibiotics because of several mechanisms by which Chlamydia can cause persistent infection. The disease may have an acute or self-limited course, however some patients develop chronic arthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341180

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  4 in total

1.  Risk of gastroschisis with maternal genitourinary infections: the US National birth defects prevention study 1997-2011.

Authors:  Marcia L Feldkamp; Kathryn E Arnold; Sergey Krikov; Jennita Reefhuis; Lynn M Almli; Cynthia A Moore; Lorenzo D Botto
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

2.  A rare entity of reactive arthritis-immune reconstitution inflammatory syndrome in an immunocompromised patient.

Authors:  Christine Katusiime
Journal:  Clin Case Rep       Date:  2019-06-23

3.  Reactive arthritis and silent thyroiditis following SARS-CoV-2 infection: Case report and review of the literature.

Authors:  Jacob Quaytman; Usha Gollamudi; Noah Bass; Shashank Suresh
Journal:  Clin Case Rep       Date:  2022-02-07

4.  Association Between Human Leukocyte Antigen-B*27 and Pathogenesis in Seronegative Spondyloarthropathies in Federation of Bosnia and Herzegovina.

Authors:  Elma Fejzić; Izet Eminović; Jasenko Karamehić; Amela Šahović; Sanela Šišić; Damir Suljević
Journal:  Arch Rheumatol       Date:  2018-09-07       Impact factor: 1.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.